Tambac, Absarijane .

HRN: 03-60-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
CEFUROXIME 500MG (TAB)
03/06/2026
03/12/2026
PO
500 MG
BID
LTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: